Overall, patients with primary Sjögren's syndrome (pSS) in a Taiwainese nationwide cohort (n = 7,852) are at no greater risk of developing cancer than the general population. However, for the 25–44-year age group the incidence of cancer was increased, with a standardized incidence ratio of 2.19 (95% CI 1.43–3.21) compared to 1.04 (95% CI 0.91–1.18) for patients with pSS over all age groups.
ORIGINAL RESEARCH PAPER
Weng, M.-Y. et al. Incidence of cancer in a nationwide population cohort of 7,852 patients with primary Sjögren's syndrome in Taiwan. Ann. Rheum. Dis. doi:10.1136/annrheumdis-2011-200402
Rights and permissions
About this article
Cite this article
Cancer risks for patients with Sjögren's syndrome. Nat Rev Rheumatol 8, 2 (2012). https://doi.org/10.1038/nrrheum.2011.196
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2011.196
